SEC Form D filing

BioIntelliSense, Inc.

Health tech · Growth · Regulation D 506(b) · CO · Filed June 4, 2026

Offering amount

$58.4M

Exemption

Reg D 506(b)

Issuer state

Filing date

June 4, 2026

Signature date

June 1, 2026

CIK

0001824134

Summary

Auto-generated

Continuous health monitoring and clinical intelligence company, $58.3M growth round in CO.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.